FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Zydus Pharmaceuticals Pramipexole DihydrochlorideTablets 0 Recall

Pramipexole DihydrochlorideTablets 0

Zydus Pharmaceuticals USA Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Jun 26, 2019
Recall ID
D-1443-2019
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals recalled Pramipexole DihydrochlorideTablets 0 starting May 6, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1443-2019 on Jun 26, 2019. Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. Status: Terminated.

Why it was recalled

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Product description

Pramipexole DihydrochlorideTablets 0.125 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-16

Lot numbers, UPCs & expiration codes

Lot: M714176, M714177, EXP Oct-19; M714917, EXP Nov-19; M714918, M715594, M715595, EXP Dec-19; M802190, EXP Jan-20; M802191, EXP Feb-20, M808673, EXP May-20; M811125, M811126, M811127, M811128, M811129, EXP Jun-20; M815082, M815083, M815084, M815085, M815086 EXP Aug-20; M900476, M900477, M900478, M900479, M900481, Dec-20;

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1443-2019
Classification
Class II
Status
Terminated
Recall initiated
May 6, 2019
FDA report date
Jun 26, 2019
Quantity
143,184 90-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals USA Inc

Original FDA data

Every field from FDA enforcement report D-1443-2019, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
82827
Address
73 Route 31 N
Code information
Lot: M714176, M714177, EXP Oct-19; M714917, EXP Nov-19; M714918, M715594, M715595, EXP Dec-19; M802190, EXP Jan-20; M802191, EXP Feb-20, M808673, EXP May-20; M811125, M811126, M811127, M811128, M811129, EXP Jun-20; M815082, M815083, M815084, M815085, M815086 EXP Aug-20; M900476, M900477, M900478, M900479, M900481, Dec-20;
Postal code
08534-3601
Report date
Jun 26, 2019
Product type
Drugs
Recall number
D-1443-2019
Classification
Class II
Recalling firm
Zydus Pharmaceuticals USA Inc
Product quantity
143,184 90-count bottles
Termination date
Sep 16, 2021
Reason for recall
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pramipexole DihydrochlorideTablets 0.125 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-16
Distribution pattern
Nationwide in the USA
Recall initiation date
May 6, 2019
Initial firm notification
Letter
Center classification date
Jul 1, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1443-2019, published Jun 26, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls